resmetirom
-
All Eyes Are on Madrigal Pharmaceuticals as FDA’s Decision Draws Closer
Later this week, the U.S. Food and Drug Administration is expected to make a decision on Madrigal Pharmaceuticals’ experimental NASH…
-
Madrigal Pharmaceuticals Plans $500 Million Stock Offering While Awaiting Nod from FDA
Conshohocken-based Madrigal Pharmaceuticals plans to raise $500 million while anticipating FDA approval of a groundbreaking therapy, writes John George for…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
